Brewin Dolphin Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $19K | Hold |
253
| – | – | ﹤0.01% | 243 |
|
|
2022
Q1 | $23K | Hold |
253
| – | – | ﹤0.01% | 241 |
|
|
2021
Q4 | $28K | Hold |
253
| – | – | ﹤0.01% | 234 |
|
|
2021
Q3 | $31.8K | Hold |
253
| – | – | ﹤0.01% | 231 |
|
|
2021
Q2 | $34.3K | Hold |
253
| – | – | ﹤0.01% | 228 |
|
|
2021
Q1 | $34.3K | Hold |
253
| – | – | 0.01% | 214 |
|
|
2020
Q4 | $35.6K | Hold |
253
| – | – | 0.01% | 185 |
|
|
2020
Q3 | $28.2K | Hold |
253
| – | – | 0.01% | 198 |
|
|
2020
Q2 | $28.3K | Buy |
+253
| New | +$28.3K | 0.01% | 190 |
|